Abstract
In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.
| Bidragets oversatte titel | Benzodiazepines should still be first-line treatment for alcohol withdrawal |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 179 |
| Udgave nummer | 3 |
| Sider (fra-til) | V07160465 |
| ISSN | 0041-5782 |
| Status | Udgivet - 16 jan. 2017 |